Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107


A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.

Kenna GA, Zywiak WH, McGeary JE, Leggio L, McGeary C, Wang S, Grenga A, Swift RM.

Alcohol Clin Exp Res. 2009 Feb;33(2):315-23. doi: 10.1111/j.1530-0277.2008.00835.x. Epub 2008 Nov 19.


Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.

Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Vuittonet C, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L.

Alcohol Clin Exp Res. 2014 Jun;38(6):1567-74. doi: 10.1111/acer.12410. Epub 2014 Apr 28.


Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.

Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L.

Alcohol. 2014 Sep;48(6):515-22. doi: 10.1016/j.alcohol.2014.04.005. Epub 2014 Aug 14.


Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.

Johnson BA, Ait-Daoud N, Seneviratne C, Roache JD, Javors MA, Wang XQ, Liu L, Penberthy JK, DiClemente CC, Li MD.

Am J Psychiatry. 2011 Mar;168(3):265-75. doi: 10.1176/appi.ajp.2010.10050755. Epub 2011 Jan 19. Erratum in: Am J Psychiatry. 2011 Jul;168(7):756.


Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy.

Thompson MD, Kenna GA.

Alcohol Alcohol. 2016 Mar;51(2):164-71. doi: 10.1093/alcalc/agv090. Epub 2015 Aug 26. Review.


A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.

Kranzler HR, Armeli S, Tennen H, Covault J, Feinn R, Arias AJ, Pettinati H, Oncken C.

J Clin Psychopharmacol. 2011 Feb;31(1):22-30. doi: 10.1097/JCP.0b013e31820465fa. Erratum in: J Clin Psychopharmacol. 2011 Oct;31(5):576.


5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity.

Kranzler HR, Armeli S, Tennen H, Covault J.

Addict Biol. 2013 Nov;18(6):1024-31. doi: 10.1111/adb.12007. Epub 2012 Nov 12.


Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence.

Kranzler HR, Armeli S, Tennen H.

Alcohol Clin Exp Res. 2012 Apr;36(4):739-44. doi: 10.1111/j.1530-0277.2011.01659.x. Epub 2011 Oct 7.


Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.

Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J.

JAMA. 2000 Aug 23-30;284(8):963-71.


Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.

Johnson BA, Seneviratne C, Wang XQ, Ait-Daoud N, Li MD.

Am J Psychiatry. 2013 Sep;170(9):1020-31. doi: 10.1176/appi.ajp.2013.12091163.


Serotonergic agents and alcoholism treatment: a simulation.

Stoltenberg SF.

Alcohol Clin Exp Res. 2003 Dec;27(12):1853-9.


Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.

Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R.

J Clin Psychopharmacol. 2003 Dec;23(6):553-62.


[Association of the functional serotonin transporter promoter polymorphism (5-HTTLPR) with externalizing and internalizing aggressivity and alcohol abuse].

Pombo S, de Quinhones Levy P, Bicho M, Barbosa A, Ismail F, Cardoso N.

Acta Med Port. 2008 Nov-Dec;21(6):539-46. Epub 2009 Mar 24. Portuguese.


Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.

Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K.

Alcohol Clin Exp Res. 2005 Mar;29(3):395-401.


Ondansetron reduces the craving of biologically predisposed alcoholics.

Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M.

Psychopharmacology (Berl). 2002 Apr;160(4):408-13. Epub 2002 Feb 12.


Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.

Reimherr F, Amsterdam J, Dunner D, Adler L, Zhang S, Williams D, Marchant B, Michelson D, Nierenberg A, Schatzberg A, Feldman P.

Psychiatry Res. 2010 Jan 30;175(1-2):67-73. doi: 10.1016/j.psychres.2009.01.005. Epub 2009 Dec 6.


A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.

Farren CK, Scimeca M, Wu R, Malley SO.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):317-21. doi: 10.1016/j.drugalcdep.2008.06.006. Epub 2008 Jul 21.


Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.

Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rukstalis MR, Cnaan A.

Alcohol Clin Exp Res. 2000 Jul;24(7):1041-9.


Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity.

Preuss UW, Soyka M, Bahlmann M, Wenzel K, Behrens S, de Jonge S, Kr├╝ger M, Bondy B.

Psychiatry Res. 2000 Sep 25;96(1):51-61.


Supplemental Content

Support Center